• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

Detection of masked hypertension in patients with metabolic-dysfunction associated steatotic liver disease using a novel clinical risk model.

作者信息

Kasper Philipp, Demir Münevver, Steffen Hans-Michael

机构信息

Faculty of Medicine and University Hospital of Cologne, Department of Gastroenterology and Hepatology, University of Cologne, Cologne, Germany.

Department of Hepatology and Gastroenterology, Charité Universitätsmedizin Berlin, Campus Virchow-Klinikum, (CVK) and Campus Charité Mitte (CCM), Berlin, Germany.

出版信息

J Hum Hypertens. 2025 Jul 11. doi: 10.1038/s41371-025-01047-z.

DOI:10.1038/s41371-025-01047-z
PMID:40646253
Abstract
摘要

相似文献

1
Detection of masked hypertension in patients with metabolic-dysfunction associated steatotic liver disease using a novel clinical risk model.使用新型临床风险模型检测代谢功能障碍相关脂肪性肝病患者的隐匿性高血压
J Hum Hypertens. 2025 Jul 11. doi: 10.1038/s41371-025-01047-z.
2
Nonalcoholic Fatty Liver非酒精性脂肪肝
3
Healthy sleep patterns and risk of incident cardiovascular disease, liver-related events, and all-cause mortality among individuals with metabolic dysfunction--associated steatotic liver disease: A large prospective cohort study.代谢功能障碍相关脂肪性肝病患者的健康睡眠模式与心血管疾病、肝脏相关事件及全因死亡率的发生风险：一项大型前瞻性队列研究
Sleep Health. 2025 Aug 22. doi: 10.1016/j.sleh.2025.07.007.
4
Quantitative ultrasound-derived fat fraction for identifying pediatric patients with metabolic dysfunction-associated steatotic liver disease: a prospective study.定量超声测定脂肪分数用于识别患有代谢功能障碍相关脂肪性肝病的儿科患者：一项前瞻性研究
Pediatr Radiol. 2025 Aug 1. doi: 10.1007/s00247-025-06349-5.
5
Metabolic Dysfunction-Associated Steatotic Liver Disease, Alcohol Consumption, and the Risk of Atrial Fibrillation: A Nationwide Population-Based Study.代谢功能障碍相关脂肪性肝病、饮酒与心房颤动风险：一项基于全国人口的研究
J Am Heart Assoc. 2025 Jul 15;14(14):e042003. doi: 10.1161/JAHA.125.042003. Epub 2025 Jul 14.
6
The Significance of the Presence of Gilbert's Syndrome in Patients With Metabolic Dysfunction-Associated Steatotic Liver Disease (MASLD): A Retrospective Cohort Study.吉尔伯特综合征在代谢功能障碍相关脂肪性肝病（MASLD）患者中的意义：一项回顾性队列研究
Cureus. 2025 May 30;17(5):e85074. doi: 10.7759/cureus.85074. eCollection 2025 May.
7
The prevalence and correlates of advanced fibrosis in patients with and without diabetes mellitus and metabolic dysfunction-associated steatotic liver disease: A cross-sectional study.糖尿病患者与非糖尿病患者以及代谢功能障碍相关脂肪性肝病患者中晚期肝纤维化的患病率及其相关因素：一项横断面研究。
J Diabetes Complications. 2025 Aug 6;39(10):109147. doi: 10.1016/j.jdiacomp.2025.109147.
8
CircDock6 drives metabolic dysfunction-associated steatotic liver disease progression in mice and mouse hepatocytes via mmu-let-7g-5p/insulin-like growth factor 1 receptor regulation.环状RNA Dock6通过调控小鼠微小RNA-let-7g-5p/胰岛素样生长因子1受体，驱动小鼠和小鼠肝细胞中与代谢功能障碍相关的脂肪性肝病进展。
J Int Med Res. 2025 Aug;53(8):3000605251362984. doi: 10.1177/03000605251362984. Epub 2025 Aug 12.
9
Impact of alcohol consumption and muscle mass on bone mineral density in metabolic dysfunction and alcohol-associated liver disease (MetALD) and metabolic dysfunction-associated steatotic liver disease (MASLD).饮酒量和肌肉量对代谢功能障碍与酒精相关肝病（MetALD）及代谢功能障碍相关脂肪性肝病（MASLD）患者骨密度的影响。
Clin Nutr ESPEN. 2025 Jul 7;69:145-153. doi: 10.1016/j.clnesp.2025.07.002.
10
Association of Neutrophil/High-Density Lipoprotein Cholesterol Ratio with Metabolic Dysfunction-Associated Steatotic Liver Disease in Type 2 Diabetes Mellitus Patients: A Cross-Sectional Study and Predictive Model Construction.2型糖尿病患者中性粒细胞/高密度脂蛋白胆固醇比值与代谢功能障碍相关脂肪性肝病的关联：一项横断面研究及预测模型构建
Diabetes Metab Syndr Obes. 2025 Jul 29;18:2597-2609. doi: 10.2147/DMSO.S528506. eCollection 2025.

本文引用的文献

1
Can we detect masked hypertension and masked uncontrolled hypertension using simple metrics? A novel clinical model for latino population.我们能否使用简单指标检测隐匿性高血压和隐匿性未控制高血压？一种针对拉丁裔人群的新型临床模型。
J Hum Hypertens. 2025 Mar;39(3):189-191. doi: 10.1038/s41371-025-00996-9. Epub 2025 Feb 22.
2
Nocturnal hypertension represents an uncontrolled burden in patients with metabolic dysfunction-associated steatotic liver disease.夜间高血压是代谢功能障碍相关脂肪性肝病患者中未得到控制的负担。
J Hypertens. 2025 May 1;43(5):814-821. doi: 10.1097/HJH.0000000000003977. Epub 2025 Feb 4.
3
Metabolic dysfunction-associated steatotic liver disease: heterogeneous pathomechanisms and effectiveness of metabolism-based treatment.
代谢功能障碍相关脂肪性肝病：异质性发病机制及基于代谢的治疗效果
Lancet Diabetes Endocrinol. 2025 Feb;13(2):134-148. doi: 10.1016/S2213-8587(24)00318-8. Epub 2024 Dec 13.
4
"Clinical prediction model for masked hypertension diagnosed by 24-h ambulatory blood pressure measurements in a sample from specialized hospital.".在一家专科医院的样本中，通过24小时动态血压测量诊断隐匿性高血压的临床预测模型。
J Hum Hypertens. 2025 Mar;39(3):199-204. doi: 10.1038/s41371-024-00980-9. Epub 2024 Nov 27.
5
Characteristics and long-term mortality of individuals with MASLD, MetALD, and ALD, and the utility of SAFE score.合并代谢相关脂肪性肝病、代谢相关酒精性肝病和酒精性肝病患者的特征及长期死亡率，以及SAFE评分的效用
JHEP Rep. 2024 Jun 3;6(10):101127. doi: 10.1016/j.jhepr.2024.101127. eCollection 2024 Oct.
6
The global epidemiology of nonalcoholic fatty liver disease (NAFLD) and nonalcoholic steatohepatitis (NASH): a systematic review.非酒精性脂肪性肝病（NAFLD）和非酒精性脂肪性肝炎（NASH）的全球流行病学：系统评价。
Hepatology. 2023 Apr 1;77(4):1335-1347. doi: 10.1097/HEP.0000000000000004. Epub 2023 Jan 3.
7
Uncontrolled hypertension: A neglected risk in patients with NAFLD.未控制的高血压：非酒精性脂肪性肝病患者中被忽视的风险。
J Intern Med. 2022 Jul;292(1):162-164. doi: 10.1111/joim.13476. Epub 2022 Mar 6.
8
Non-alcoholic fatty liver disease and risk of fatal and non-fatal cardiovascular events: an updated systematic review and meta-analysis.非酒精性脂肪性肝病与致死和非致死性心血管事件风险：一项更新的系统评价和荟萃分析。
Lancet Gastroenterol Hepatol. 2021 Nov;6(11):903-913. doi: 10.1016/S2468-1253(21)00308-3. Epub 2021 Sep 21.
9
NAFLD and cardiovascular diseases: a clinical review.非酒精性脂肪性肝病与心血管疾病：临床综述。
Clin Res Cardiol. 2021 Jul;110(7):921-937. doi: 10.1007/s00392-020-01709-7. Epub 2020 Jul 21.